I think your post alone caused the premarket to jump $.20 good job ---- and not a baseless pump either.
Management is making sure it's going to have enough cash to further its goals and not be vulnerable to a low-ball offer from a big pharma/biotech. In other words, the company is doing everything right.
You've made quite enough on this decline; remember "Pigs get slaughtered."
Finally an intelligent voice in the roar of idiots. Thank you. The "50-day" info was important.
Sentiment: Strong Buy
$8.10 is support; don't be surprised to see it get there early a.m . with bounce to $8.45 later. If it closes below $8.10 ---- a very bearish sign, folks.
Three times I have averaged down for a profit each time. I'm hoping it goes down tomorrow as I have a bunch of cash to get rid of after all Christmas gifts have been taken care of.
Should have at least a gap up to $9.10. Congrats all longs .With short covering could go higher, maybe even $9.50 !!!
Buying more in the premarket for a decent gap up.
And THEN we'll get back to $5.50 in a heart beat. I feel sorry for those that sold because of the SA articles, at least the negative ones. The positive one said it all and in very understandable terms.
With all the bashing, stock was up 2.18 % in a down market; we'll see that today again with reduced volatility. A nice nice slow ascent back up to the mid $5s is ahead CAMT has technology that is needed out there.
I am happy that I only had enough cash to buy 50 shares five minutes before the dilution info came out. The poster that said we should have paid attention to the insider selling .... Oh well, I could have bought 1K shares instead of 50. Good thing I had to wait for my sale of "YY" to clear before I had another $8K to invest. Whew. Oh, ONVO will be back to $9.50 in a week or so after the market realizes that dilution is just part of the story of a start up company. Notice they said shares will be sold "at the market" not some ridiculously low price per share. Just hold and average down every 50 cents the share price declines.
$60 remains 1 yr target.